Company Analysis FibroGen
1. Summary
Advantages
- The stock's return over the last year (106.56%) is higher than the sector average (-44.23%).
- The company's current efficiency (ROE=139.22%) is higher than the sector average (ROE=0%)
Disadvantages
- Price (1.26 $) is higher than fair price (0.6196 $)
- Dividends (0%) are below the sector average (0%).
- Current debt level 20.32% has increased over 5 years from 11.04%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| FibroGen | ΠΠ΅ΡΡΠ΅Π³Π°Π· | Index | |
|---|---|---|---|
| 7 days | 243.6% | -33.8% | 1.7% |
| 90 days | 18.9% | -48.8% | 16.3% |
| 1 year | 106.6% | -44.2% | 37.8% |
FGEN vs Sector: FibroGen has outperformed the "ΠΠ΅ΡΡΠ΅Π³Π°Π·" sector by 150.78% over the past year.
FGEN vs Market: FibroGen has outperformed the market by 68.71% over the past year.
Stable price: FGEN is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: FGEN with weekly volatility of 2.05% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1.26 $) is higher than the fair price (0.6196 $).
Price is higher than fair: The current price (1.26 $) is 50.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (48.12).
4.3. P/BV
P/BV vs Sector: The company's P/BV (-11.46) is lower than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (-11.46) is lower than that of the market as a whole (3.1).
4.4. P/S
P/S vs Sector: The company's P/S indicator (12.58) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (12.58) is higher than that of the market as a whole (10.15).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-7.39) is lower than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (-7.39) is lower than that of the market as a whole (18.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 53.83% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (53.83%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (139.22%) is higher than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (139.22%) is higher than that of the market as a whole (10.88%).
5.5. ROA
ROA vs Sector: The company's ROA (-67.11%) is lower than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (-67.11%) is lower than that of the market as a whole (6.5%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-84.49%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (-84.49%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 07.03.2024 | Wettig Thane CEO |
Purchase | 1.91 | 95 500 | 50 000 |
| 04.08.2023 | Henderson Jeffrey William Director |
Sale | 1.91 | 3 820 | 2 000 |
| 11.07.2023 | Henderson Jeffrey William Director |
Sale | 2.69 | 5 380 | 2 000 |
| 07.07.2023 | Conterno Enrique A Chief Executive Officer |
Sale | 2.8 | 5 264 | 1 880 |
| 09.06.2023 | EDWARDS JEFFREY L Director |
Sale | 17.19 | 135 612 | 7 889 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
